Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
X Bioscience PCLBKK:XBIO Median PS Value is ฿0.11 as of Aug. 25, 2026. The stock has 6 warning signs investors should review. Among 219 Restaurants companies, X Bioscience PCL ranks better than 64.84% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
X Bioscience PCL (BKK:XBIO) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
X Bioscience PCL's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.07
/
0.11
=
0.64
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
X Bioscience PCL Median PS Value Related Terms
X Bioscience PCL Median PS Value Historical Data
* Premium members only.
The historical data trend for X Bioscience PCL's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BKK:XBIO vs SYY, USFD, PFGC: Median PS Value Comparison
For the Restaurants subindustry, X Bioscience PCL's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
X Bioscience PCL Price-to-Median-PS-Value vs Restaurants Industry
For the Restaurants industry and Consumer Cyclical sector, X Bioscience PCL's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where X Bioscience PCL's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.8333.
X Bioscience PCL's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.06.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
X Bioscience PCL (BKK:XBIO) has a Median PS Value of ฿0.11 as of Aug. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on X Bioscience PCL and its competitors. According to the industry distribution chart, X Bioscience PCL ranks #77 out of 219 companies in the Restaurants industry, placing it in the top 35.2%.
Is X Bioscience PCL's Median PS Value too high?
X Bioscience PCL's current Median PS Value is ฿0.11. Based on the distribution chart, X Bioscience PCL ranks #77 out of 219 companies in the Restaurants industry, which is above the industry midpoint.
How does X Bioscience PCL's Median PS Value compare to SYY and USFD?
According to the Restaurants industry distribution chart, X Bioscience PCL ranks #77 out of 219 companies for Median PS Value. This puts X Bioscience PCL in the upper half of its industry. The industry median Median PS Value is 0.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Restaurants company?
The median Median PS Value among Restaurants companies is 0.80, based on 219 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on X Bioscience PCL and its competitors. For the Restaurants industry, the median Median PS Value is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. X Bioscience PCL's current Median PS Value is ฿0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is X Bioscience PCL stock overvalued right now?
Based on GuruFocus' analysis, X Bioscience PCL (BKK:XBIO) is currently considered Possible Value Trap. The stock's GF Value™ is ฿0.10, compared to a current price of ฿0.07 — trading 30% below its estimated fair value. The current Median PS Value is ฿0.11. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For X Bioscience PCL (BKK:XBIO), the current Median PS Value is ฿0.11 as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
X Bioscience PCL, along with its subsidiaries, is mainly engaged in selling food and beverages by operating restaurants and bakery shops under the Le Boeuf, Kagonoya, Bake Cheese Tart, Croquant Chou ZakuZaku, and RAPL trademarks. Additionally, the Group is involved in the production and distribution of biological products. It operates in two business segments: the food and beverage sales segment, which generates maximum revenue, and the production and distribution of biological products segment. Geographically, the Group operates only in Thailand.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:XBIO has been successfully added to your 
